Title |
Current Advances in Retroviral Gene Therapy
|
---|---|
Published in |
Current Gene Therapy, June 2011
|
DOI | 10.2174/156652311795684740 |
Pubmed ID | |
Authors |
Youngsuk Yi, Moon Jong Noh, Kwan Hee Lee |
Abstract |
There have been major changes since the incidents of leukemia development in X-SCID patients after the treatments using retroviral gene therapy. Due to the risk of oncogenesis caused by retroviral insertional activation of host genes, most of the efforts focused on the lentiviral therapies. However, a relative clonal dominance was detected in a patient with β-thalassemia Major, two years after the subject received genetically modified hematopoietic stem cells using lentiviral vectors. This disappointing result of the recent clinical trial using lentiviral vector tells us that the current and most advanced vector systems does not have enough safety. In this review, various safety features that have been tried for the retroviral gene therapy are introduced and the possible new ways of improvements are discussed. Additional feature of chromatin insulators, co-transduction of a suicidal gene under the control of an inducible promoter, conditional expression of the transgene only in appropriate target cells, targeted transduction, cell type-specific expression, targeted local administration, splitting of the viral genome, and site specific insertion of retroviral vector are discussed here. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 3 | 1% |
Russia | 2 | <1% |
United Kingdom | 2 | <1% |
Netherlands | 1 | <1% |
Indonesia | 1 | <1% |
South Africa | 1 | <1% |
Sri Lanka | 1 | <1% |
United States | 1 | <1% |
Unknown | 246 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 55 | 21% |
Student > Bachelor | 47 | 18% |
Student > Master | 46 | 18% |
Researcher | 21 | 8% |
Student > Postgraduate | 14 | 5% |
Other | 32 | 12% |
Unknown | 43 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 81 | 31% |
Biochemistry, Genetics and Molecular Biology | 49 | 19% |
Medicine and Dentistry | 45 | 17% |
Immunology and Microbiology | 8 | 3% |
Chemistry | 8 | 3% |
Other | 19 | 7% |
Unknown | 48 | 19% |